Stock APLLTD ALEMBIC PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Alembic Pharmaceuticals Limited

Equities

APLLTD

INE901L01018

Market Closed - NSE India S.E.
Other stock markets
 07:43:51 2024-05-31 am EDT 		5-day change 1st Jan Change
923.1 INR -2.05% Intraday chart for Alembic Pharmaceuticals Limited -2.83% +21.56%
May. 30 Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets MT
May. 09 Transcript : Alembic Pharmaceuticals Limited, Q4 2024 Earnings Call, May 09, 2024

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets
MT
Alembic Pharmaceuticals' Consolidated Net Profit Jumps in Fiscal Q4
MT
India's Alembic Pharma posts higher Q4 profit on strong N.America sales
RE
Alembic Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
CI
Alembic Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Alembic Pharmaceuticals Limited Recommends Dividend for the Financial Year 2023-24
CI
Alembic Pharmaceuticals Limited Receives Various US Food & Drug Administration (Tentative or Final) Product Approvals
CI
Alembic Pharmaceuticals Board to Consider Dividend for Fiscal 2024; Shares Drop 3%
MT
Alembic Pharmaceuticals Gets US FDA Tentative Nod for Generic Breast Cancer Treatment
MT
Alembic Pharmaceuticals Limited Receives One US Food & Drug Administration Product Approval
CI
Alembic Pharmaceuticals' Oncology Plant in Gujarat, India Gets One Observation from US FDA
MT
Indian shares seen muted tracking broader Asian equities
RE
Alembic Pharmaceuticals' Consolidated Net Profit Jumps in Fiscal Q3; EPS Tops Estimates
MT
Alembic Pharmaceuticals' Consolidated Profit Climbs in Fiscal Q3, EPS Beats Estimates
MT
India's Alembic Pharma beats Q3 profit view on strong domestic, US sales
RE
Alembic Pharmaceuticals Extends Corporate Guarantee to US-Based Arm to Secure Credit
MT
Alembic Pharmaceuticals Receives Various Us Food & Drug Administration Product Approvals
CI
Alembic Pharmaceuticals Logs Slightly Higher Consolidated Profit in Fiscal Q2; EPS Misses Estimates
MT
India's Alembic Pharma Q2 profit roughly in-line with estimates
RE
Alembic Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. APLLTD Stock
  4. News Alembic Pharmaceuticals Limited
  5. Highlights